Quotes with Resistance & Support
Market Information

Aventis Pharma a market performer: Karvy

Posted on: February 19th, 2009 and is filed under Brokerage Recommendations.

Karvy Stock Broking has rated Aventis Pharma as a market performer with a target price of Rs 876 in its February 19, 2009 research report. “Revenues for the quarter were up by 32.3% to Rs 2699 million. This was mainly driven by strong growth in domestic formulations business of 18% to Rs 2011 million while exports showed good traction with revenues of Rs 688 million which is much higher than Rs 522 million achieved in the preceeding quarter.

Operating margins were higher at 22% as against 18.6% in the corresponding quarter of the previous year. The margins were better on account of better product mix and traction in exports. Profits for the quarter were up by 68% to Rs 453 million. We downgrade our price target by 20% to Rs 876 based on 14x CY 2009E. We downgrade our rating on the stock to market performer,” says Karvy Stock Broking’s research report.

Tags: , , , ,

Similar Posts:


+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments